Wordt geladen...
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is an incurable cancer resistant to traditional treatments, although a limited number of early-stage patients can undergo radical resection. Immunotherapies for the treatment of haematological malignancies as well as solid tumours have been substantially impro...
Bewaard in:
| Gepubliceerd in: | Mol Cancer |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7023714/ https://ncbi.nlm.nih.gov/pubmed/32061257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01151-3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|